DDW 2026: Targeted Pancreatic Diagnostics Sessions You Won’t Want to Miss

ChiRhoClin invites you to add these DDW sessions to your agenda as experts discuss pancreatitis, pancreatic juice biomarker discovery, expanded genetic testing, and pancreatic cancer screening and connect with ChiRhoClin to learn more about Human Secretin for Injection.

Sunday, May 3 | 12:30 PM
Dr. Majumder and colleagues, Mayo Clinic
“Assessment of Small RNAs in Pancreatic Juice and Extracellular Vesicles for Biomarker Discovery Optimization”

Monday, May 4 | 4:45 PM
Dr. Maisam Abu-El-Haija, Cincinnati Children’s Hospital Medical Center
“Expanded Genetic Testing in Patients with Recurrent Acute and Chronic Pancreatitis Reveals New Variants Linked to the Disease”

Tuesday, May 5 | 12:30 PM
Dr. Majumder and Dr. Kupfer
“Pancreatic Cancer Screening: Who, What When”

These presentations highlight continued momentum in pancreatic diagnostics and early detection. DDW 2026 is an opportunity to hear from leaders in the field and stay current on emerging science shaping pancreatic disease evaluation.

Interested in learning more about ChiRhoStim® (Human Secretin for Injection)? Contact spurich@chirhoclin.com for more information.